We are thrilled to see DNlite's predictive technology increasingly adopted by primary care clinics across Taiwan, delivering true precision medicine to patients with diabetes.
Recently, Dr. Hung-Lin Chen, President of the Taiwan Primary Care Diabetes Association, was featured in an exclusive interview with Hello Yishi (a leading health media platform) to discuss the paradigm shift in combating Chronic Kidney Disease (CKD).
In the interview, Dr. Chen highlighted a critical message: "We must transition from passive treatment to proactive prediction." He emphasized how innovative biomarkers like DNlite empower primary care physicians to overcome the diagnostic blind spots of traditional tests, identifying high-risk patients long before irreversible structural damage occurs.
????️ Watch the highlight reel (Mandarin) to see how DNlite is changing the game in primary care:
* Facebook:https://www.facebook.com/share/1C5E1mJbWN/
* Youtube:https://www.youtube.com/watch?v=26xnJFSDXpA
* Eventsite:https://helloyishi-event.com/event.php?id=10
Related News
BPM Sets a New Record: DNlite-IVD103 Secures Dual SFDA Approvals in Saudi Arabia
BPM Sets a New Record: DNlite-IVD103 Secures Dual SFDA Approvals in Saudi Arabia
2023/12/08
Press
[Regulatory Milestone] BPM’s DNlite-IVD103 Successfully Achieves EU IVDR Certification, Accelerating Global Market Expansion
[Regulatory Milestone] BPM’s DNlite-IVD103 Successfully Achieves EU IVDR Certification, Accelerating Global Market Expansion
2024/09/30
Press
BPM Secures CE IVD Mark for DNlite-IVD103
The World's First Innovative Diagnostic Kit for Preventing Rapid Decline in Diabetic Kidney Disease
2020/02/11
Press